Skin Patents (Class 623/15.12)
-
Patent number: 11707492Abstract: Methods of treating a complex wound by administering to a complex wound in the individual a therapeutically effective amount of a fetal support tissue product to treat the complex wound. Methods of treating a complex lower extremity ulcer by administering to a complex lower extremity ulcer in the individual a therapeutically effective amount of a fetal support tissue product to treat the complex lower extremity ulcer. Methods of reducing or preventing scar formation from granulation tissue by administering a fetal support tissue product to granulation tissue. Methods of repairing a spina bifida defect by administering to the defect in the individual a therapeutically effective amount of an umbilical cord product.Type: GrantFiled: January 27, 2017Date of Patent: July 25, 2023Assignee: BIOTISSUE HOLDINGS INC.Inventor: Scheffer Tseng
-
Patent number: 11105795Abstract: Methods and compositions for simulating a dermal compartment of skin are disclosed. In one aspect of the invention, methods of producing such a skin model include the steps of admixing a collagenous protein source, a blood protein source, and dermal cells in an aqueous carrier, and then allowing the resulting mixture to solidify to produce a gel. In one technique, at least a portion of the mixture, e.g., the collagenous protein source is first heated and then cooled to induce gelation. For example, the mixture can be heated to at least 50 degrees C. and then cooled to temperature below 5 degrees C. to induce gelation.Type: GrantFiled: January 8, 2019Date of Patent: August 31, 2021Assignee: ClearIt, LLCInventors: James W. Winkelman, Martin E. Schmieg
-
Patent number: 11006974Abstract: The present application relates to devices and methods for harvesting skin graft sheets. The present invention provides a blister raising device comprising a blade assembly for cutting a blister sheet and an array of protrusions configured to prevent a portion of skin at the donor site from blistering.Type: GrantFiled: November 3, 2016Date of Patent: May 18, 2021Assignee: KCI LICENSING, INC.Inventor: T. Blane Sanders
-
Patent number: 10874697Abstract: Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane.Type: GrantFiled: September 26, 2017Date of Patent: December 29, 2020Assignee: MiMedx Group, Inc.Inventors: John Daniel, Randall Spencer, John Russo, Robert Tofe
-
Patent number: 10130551Abstract: A condom features a generally cylindrical sheath with an open proximal end and a distal end that fits onto a male penis. The condom also features a tether which is connected at the distal end of the sheath. The tether has an axial length greater than the axial length of the sheath and is designed to be grasped by a female partner during intercourse and placed into a rubbing contact with the clitoris.Type: GrantFiled: April 3, 2014Date of Patent: November 20, 2018Inventor: Conrad Flick
-
Patent number: 10065046Abstract: Embodiments of the present invention relate generally to the field of tissue repair and regeneration. More specifically, embodiments of the present invention relate to medical devices, materials or constructs, such as conductive biocompatible polymers having one or more networks of metal nanowires that enhance tissue repair and regeneration using electromagnetic fields.Type: GrantFiled: July 15, 2011Date of Patent: September 4, 2018Assignee: Fibralign CorporationInventors: Michael Paukshto, George Martin, John Cooke
-
Patent number: 9265715Abstract: Compositions comprising an organic sunscreen in combination with (i) nylon particles, (ii) silica particles, and (iii) barium sulfate particles provide an improvement in SPF as compared to an otherwise identical composition lacking any one of the three ingredients (i)-(iii). The compositions advantageously provide high diffuse transmittance, giving a natural look to the skin.Type: GrantFiled: September 30, 2015Date of Patent: February 23, 2016Assignee: Avon Products, Inc.Inventors: Juliana Fanizza, Ashley L. Howell, William E. McNamara
-
Publication number: 20150119986Abstract: A system for performing minimally invasive facelifts is provided. The system includes a plate having a base having a top surface and an opposing bottom surface. The base has a plurality of through holes formed therein that extends between the top surface and the bottom surface. A plurality of barbs extends outwardly from the bottom surface. At least one anchor screw is adapted to secure the plate to the bone of patients. A method for performing minimally invasive facelifts is also provided.Type: ApplicationFiled: October 24, 2014Publication date: April 30, 2015Inventor: Francisco PICO-Fazzi
-
Publication number: 20150119985Abstract: The present invention relates to a filler for removing wrinkles, comprising: a slim and long tubular main body penetrating through the subcutaneous tissue; and a through-hole provided so as to enable the cells of the peripheral tissue of the main body to move to the inside of the main body so as to form a fibrous tissue, the through-hole being formed so as to communicate with a hollow portion formed inside the main body in the longitudinal direction from the outer peripheral surface of the main body. The filler for removing wrinkles according to the present invention is not deformed or moved by the pressure of a skin or external forces after being inserted into the subcutaneous tissue, and can be applied to various body parts having wrinkles, including body parts having deep wrinkles so as to achieve (semi)permanent effects.Type: ApplicationFiled: May 10, 2013Publication date: April 30, 2015Applicants: HB MEDICALS, CO., LTD., PACIFICPHARMA CORPORATIONInventors: Hoon Bum Lee, Won Seok Park, Hyuk Kim, Ho Sang Yoon, Jang Yeon Lee
-
Patent number: 9017405Abstract: An improved skin substitute is presented comprised of a silicone layer backed up with a woven nylon fabric layer, the silicone layer possessing a regular pattern of slits that permit the porosity of the skin substitute to be adjusted by clinicians by means of applying tension to the skin substitute that differentially opens the slits. A variety of therapeutic substances can be applied to the skin substitute to promote healing, including aloe and other medicinal preparations.Type: GrantFiled: May 19, 2013Date of Patent: April 28, 2015Inventor: E. Aubrey Woodroof
-
Patent number: 8992613Abstract: The invention relates to a method for producing an unshrunken tissue equivalent. Said method is comprising in that: a mixture is produced that contains at least one element of an extracellular matrix; at least one pluridimensional medium is soaked with said mixture; from the components of the mixture, a lattice comprising at least one element of an extracellular matrix is produced, at least at the medium; at least part of the components of said mixture is attached to the structure of the medium; the shrinking of at least the lattice is prevented and at least said lattice is tensioned on said medium; fibroblasts are integrated into the lattice and at least one cell culture of said fibroblasts is carried out, at least in the lattice. The invention also relates to a method for producing a skin equivalent that comprises at least one dermal equivalent formed by an unshrunken tissue equivalent and at least one epidermal equivalent.Type: GrantFiled: July 1, 2010Date of Patent: March 31, 2015Assignees: Universite de Franche-Comte, Centre Hospitalier Universitaire de BesanconInventors: Philippe Humbert, Delphine Binda, Celine Viennet-Steiner, Sophie Robin, Helene Tauzin, Gwenael Rolin, Lionel Pazart
-
Publication number: 20150057751Abstract: An acellular dermal graft is provided. The acellular dermal graft may be useful in minimizing side effects caused after transplantation since an environment favorable for formation of new blood vessels and proliferation of autologous tissues is provided by forming a multi-penetration structure in an acellular dermal tissue, removing a basement membrane layer and/or subjecting corners to slope cutting, and transplantation is stably performed within a short transplantation time due to improved extensibility and flexibility of tissues. The acellular dermal graft may be useful in reducing a time required to recover tissues after transplantation since the transplantation is stably performed due to improved grafting reaction with a host tissue by enhancing uptake of fibroblasts and promoting angiogenic activities.Type: ApplicationFiled: September 11, 2014Publication date: February 26, 2015Inventors: Joon Yong KIM, Byung Moo KIM, Yong Sup HWANG, Whan Chul LEE, Soo Jeong SEO, Ju Hee LEE, Hyung Gu KIM
-
Publication number: 20150018948Abstract: Provided herein is a tissue stretching device configured for orbicular expansion of a tissue placed therein. Methods of use of the device to stretch a tissue as well as for culturing organized tissues are also provided. Stretched and/or cultured tissues produced by these processes are also provided, as well as methods making use of the same.Type: ApplicationFiled: July 8, 2014Publication date: January 15, 2015Inventors: Rohan A. Shirwaiker, Caroline Elsie Webster, John D. Jackson, Richard A. Wysk, Sang Jin Lee, Ola L.A. Harrysson, James J. Yoo, Anthony Atala, Paul H. Cohen, Yuan-Shin Lee, Peter M. Prim, Molly F. Purser, Katie L. Basinger
-
Publication number: 20150011593Abstract: The present invention relates to a method for producing artificial skin, comprising: adding a matrix metalloproteinase inhibitor and a heparanase inhibitor to an artificial skin formation culture medium comprising human epidermal keratinocytes and human dermal fibroblasts, culturing the cells in the artificial skin formation culture medium, and forming artificial skin.Type: ApplicationFiled: September 25, 2014Publication date: January 8, 2015Applicant: Shiseido Company, Ltd,Inventors: Shunsuke IRIYAMA, Kenichi UMISHIO, Makoto TSUNENAGA, Shinji INOMATA, Eijiro ADACHI
-
Publication number: 20140350680Abstract: The present invention relates to a process for modifying the surface morphology of a medical device. The modified surface has, among other advantageous properties, an improved capacity for sorption or conjugation of a variety of bioactive agents, the addition of which will turn the medical device into a localized drug delivery system.Type: ApplicationFiled: December 22, 2012Publication date: November 27, 2014Inventors: Dang Quang Svend Le, Muwan Chen, Menglin Chen, Anette Overgaard Baatrup, Cody Eric Bünger, Helle Lysdahl, Jørgen Kjems, Morten Østergaard Andersen, Flemming Besenbacher
-
Publication number: 20140343676Abstract: An improved skin substitute is presented comprised of a silicone layer backed up with a woven nylon fabric layer, the silicone layer possessing a regular pattern of slits that permit the porosity of the skin substitute to be adjusted by clinicians by means of applying tension to the skin substitute that differentially opens the slits. A variety of therapeutic substances can be applied to the skin substitute to promote healing, including aloe and other medicinal preparations.Type: ApplicationFiled: May 19, 2013Publication date: November 20, 2014Inventor: Aubrey Woodroof
-
Publication number: 20140287020Abstract: A device, and method of making the device, capable of therapeutic treatment and/or for in vitro testing of human skin. The device may be used on skin wounds for burned, injured, or diseased skin, and provides structures and functions as in normal uninjured skin, such as barrier function, which is a definitive property of normal skin. The device contains cultured dermal and epidermal cells on a biocompatible, biodegradable reticulated matrix. All or part of the cells may be autologous, from the recipient of the cultured skin device, which advantageously eliminates concerns of tissue compatibility. The cells may also be modified genetically to provide one or more factors to facilitate healing of the engrafted skin replacement, such as an angiogenic factor to stimulate growth of blood vessels.Type: ApplicationFiled: June 9, 2014Publication date: September 25, 2014Applicants: University of Cincinnati, Shriners Hospitals for ChildrenInventor: Steven T. Boyce
-
Publication number: 20140276957Abstract: Allografts for soft tissue repair, including breast reconstruction and other plastic surgery procedures, are disclosed. One allograft is made from decellularized dermal tissue and constitutes a collagen matrix having substantially uniform density and porosity. Another allograft is a hybrid bilayer tissue form that is made from decellularized dermal and adipose tissues. Methods for making both allografts are also disclosed.Type: ApplicationFiled: March 13, 2014Publication date: September 18, 2014Applicant: MUSCULOSKELETAL TRANSPLANT FOUNDATIONInventors: Michael Locarno, Bryan J. Choi, Mahn-Dan Ngo
-
Publication number: 20140277454Abstract: Methods and devices for management of fluids during skin graft transplantation are disclosed. In one aspect of the invention, absorbent substrates for transplanting skin grafts are disclosed having a surface adapted to contact at least one excised skin graft and engage said graft for removal from a donor site; a sealing member at least partially surrounding an absorbent material disposed within the enclosure; wherein at least a portion of the skin-contacting surface is porous and in fluid communication with the absorbent layer to capture fluids.Type: ApplicationFiled: March 14, 2014Publication date: September 18, 2014Applicant: KCI Licensing, Inc.Inventors: Christopher Brian Locke, Timothy Mark Robinson, John R. Harper
-
Patent number: 8790636Abstract: The present invention relates generally to compositions for wound closure. More specifically, the present invention provides human skin equivalents engineered to express exogenous polypeptides (e.g., antimicrobial polypeptides and keratinocyte growth factor 2) and compositions and methods for making human skin equivalents engineered to express exogenous polypeptides. In addition, the present invention provides methods for treatment of wounds with human skin equivalents engineered to express exogenous polypeptides.Type: GrantFiled: January 4, 2012Date of Patent: July 29, 2014Assignee: Stratatech CorporationInventors: John M. Centanni, B. Lynn Allen-Hoffmann
-
Patent number: 8747467Abstract: The present invention is directed to a composition comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. Also disclosed is a tissue graft or implant comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. The composition and/or tissue graft or implant of the invention is usable in combination with seeded cells, a tissue growth factor, and/or a chemotactic agent to attract a desired cell.Type: GrantFiled: February 7, 2013Date of Patent: June 10, 2014Assignee: RTI Surgical, Inc.Inventors: C. Randal Mills, John R. Bianchi, Michael R. Roberts, David T. Cheung, Chandrasekaran Nataraj, John W. Howell
-
Patent number: 8728466Abstract: This document provides methods and materials involved in treating burn injuries. For example, methods and materials for using skin grafts (e.g., autologous skin grafts) treated with an autologous platelet concentrate and autologous thrombin to treat burn injuries (e.g., deep skin burn injuries) are provided.Type: GrantFiled: November 22, 2011Date of Patent: May 20, 2014Assignee: University Hospital OstravaInventors: Vaclav Prochazka, Hana Klosova, Giannoula Lakka Klement
-
Patent number: 8728170Abstract: A bioerodible conductive tissue scaffold that can provide, e.g., improved tissue growth.Type: GrantFiled: March 30, 2007Date of Patent: May 20, 2014Assignee: Boston Scientific SciMed, Inc.Inventors: Liliana Atanasoska, James Q. Feng, Jan Weber, James Lee Shippy, III
-
Patent number: 8709081Abstract: A cellular scaffold that is suitable for tissue regeneration, cell culture and in vitro assays. The invention relates to a layered cell scaffold that is seeded with mesenchymal and ectodermal cells. The layered cellular scaffold comprises an inoculum of mesenchymal cells and ectodermal cells positioned between two opposing scaffolds in a sandwich configuration. The layered cell scaffold provides a functional skin equivalent that is suitable for transplantation and in vitro cell-based assays.Type: GrantFiled: October 2, 2011Date of Patent: April 29, 2014Assignee: Stemedica Cell Technologies, Inc.Inventors: Alexander Kharazi, Ludmilla Kharazi, Nikolai Tankovich
-
Publication number: 20140067064Abstract: The present invention relates generally to systems and methods for preparing, storing, shipping and using skin equivalents made by organotypic culture. In particular, the present invention relates to systems and methods for producing, transporting, storing and using skin equivalents produced by organotypic culture at reduced temperatures, preferably from 2-8 degrees Celsius to ambient temperature. The methods include sterile packaging of the grafts so that the sterility and integrity of the package is maintained until the time of use for grafting purposes.Type: ApplicationFiled: October 15, 2013Publication date: March 6, 2014Inventors: Allen R. Comer, B. Lynn Allen-Hoffmann, Barry Steiglitz
-
Publication number: 20130289724Abstract: An improved wound dressing is described. The wound dressing contains an allograft having at least one layer of human amnion and chorion tissues that has a size and shape appropriate for covering a wound, a base sheet for securing the allograft over the wound, and optionally a support layer to protect the allograft. Methods of preparing the wound dressing and using it in wound healing are also described. The products and methods improve the performance of the wound healing, e.g., by accelerating wound healing, reducing scar formation, inflammation and risk of infection.Type: ApplicationFiled: March 14, 2013Publication date: October 31, 2013Applicant: AFCELL MEDICALInventor: Robin R. YOUNG
-
Publication number: 20130238092Abstract: A composite comprising a stem cell; a biodegradable layer, which can provide an environment for the stem cell to grow and to differentiate, and; a N-isopropylacrylamide (NIPAAm), which can polymerize with the biodegradable layer and possess the temperature-responsive character for easy stripping. The present invention further provides a method for treating a patient with a skin defect, consisting of (a) providing said patient with a composite consisting of a N-isopropylacrylamide (NIPAAm) layer polymerized with a biodegradable layer containing gelatin and a layer of polypropylene (PP) non-woven, wherein a bone marrow derived mononuclear cell with CD45 negative and glycophorin A negative is cultivating on the biodegradable layer; (b) covering said composite on the skin defect of the patient; and (c) treating the composite with water below 25° C. to strip off the layer of polypropylene (PP) non-woven.Type: ApplicationFiled: April 17, 2013Publication date: September 12, 2013Applicant: Taipei Veterans General HospitalInventors: Shih-Hwa Chiou, Cherng-Kang Perng, Han-Tzo Lin, Yi-Ping Yang
-
Publication number: 20130218274Abstract: Described herein are shredded tissue grafts composed of one or more placental components. The compositions have numerous medical applications with respect to wound healing and complications associated with wound healing. Methods for making the shredded tissue graft compositions are also described herein.Type: ApplicationFiled: November 28, 2012Publication date: August 22, 2013Applicant: MIMEDX GROUP, INC.Inventor: MIMEDX GROUP, INC.
-
Publication number: 20130184821Abstract: The present invention provides a method of treating a leg ulcer comprising contacting the leg ulcer with a collagen biofabric. The leg ulcer may be a venous, arterial, diabetic or decubitus (pressure) ulcer. The invention further provides kits comprising one or more pieces of collagen biofabric for the treatment of a leg ulcer.Type: ApplicationFiled: December 11, 2012Publication date: July 18, 2013Applicant: Anthrogenesis CorporationInventor: Anthrogenesis Corporation
-
Publication number: 20130158658Abstract: The present disclosure provides a tissue product comprising a tissue sheet. The sheet can be formed from a plurality of tissue matrix fragments.Type: ApplicationFiled: December 18, 2012Publication date: June 20, 2013Inventor: Mark Hayzlett
-
Publication number: 20130103151Abstract: Embodiments of the present invention provide Dermal Micro-organs (DMOs), methods and apparatuses for harvesting the same. Some embodiments of the invention provide a DMO including a plurality of dermal components, which substantially retain the micro-architecture and three dimensional structure of the dermal tissue from which they are derived. An apparatus for harvesting the DMO may include, according to some exemplary embodiments, a support configuration to support a skin-related tissue structure from which the DMO is to be harvested, and a cutting tool able to separate the DMO from the skin-related tissue structure. Exemplary embodiments of the invention provide a genetically modified dermal micro-organ expressing at least one recombinant gene product. Some embodiments of the invention provide methods and apparatuses for implanting a genetically modified DMO.Type: ApplicationFiled: December 2, 2012Publication date: April 25, 2013Applicant: MEDGENICS MEDICAL ISRAEL LTDInventor: Medgenics Medical Israel Ltd
-
Publication number: 20130085570Abstract: Devices, kits and/or methods for, or related to, creating a plurality of openings in a skin graft or skin substitute are described. The devices can have a plurality of perforating elements extending from a perforation component that can be safely held and manipulated by a user. The user can apply sufficient force to the perforating elements against the skin graft or skin substitute to enable the extended ends of the perforating elements to pass through the skin graft or skin substitute as to create openings therethrough.Type: ApplicationFiled: September 30, 2011Publication date: April 4, 2013Inventor: Karce Daniel Rose
-
Publication number: 20130085571Abstract: An artificial, biodegradable skin scaffold includes a biodegradable polysaccharide hydrogel composition having a Young's modulus of at least about 10 MPa and, preferably, includes an additional biodegradable polysaccharide hydrogel composition with the two biodegradable polysaccharide hydrogel compositions contacting one another and the additional biodegradable polysaccharide hydrogel composition preferably having a Young's modulus of less than about 10 MPa.Type: ApplicationFiled: May 14, 2010Publication date: April 4, 2013Inventors: Anja Mueller, Robert D. Kross
-
Patent number: 8394141Abstract: The present invention is directed to a composition comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. Also disclosed is a tissue graft or implant comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. The composition and/or tissue graft or implant of the invention is usable in combination with seeded cells, a tissue growth factor, and/or a chemotactic gent to attract a desired cell.Type: GrantFiled: September 9, 2010Date of Patent: March 12, 2013Assignee: RTI Biologics, Inc.Inventors: C. Randal Mills, John R. Bianchi, Michael R. Roberts, David T. Cheung, Chandrasekaran Nataraj, John W. Howell
-
Publication number: 20130060335Abstract: The invention provides a description of a method and a device suitable for producing a cell suspension spray with living cells, and the produced cell preparation, suitable for grafting to a patient. In contrast to other methods, the spraying is performed through a disposable needle which is inserted into a disposable air tube; which provides a cell distribution avoiding spray nozzles. Small suspension droplets are provided instead of cell nebulization. By using medical grade sterile Luer-lock disposables from medical routine praxis, biocompatibility and easy application is addressed. In applying the method and/or in using the device, cells suitable for grafting to a patient are dispersed in a solution and sprayed with the device for distribution over the recipient graft site.Type: ApplicationFiled: August 13, 2012Publication date: March 7, 2013Inventor: Reinhard Bornemann
-
Publication number: 20130053938Abstract: A molecular plasma deposition (MPD) method in combination with an atomic layer deposition (ALD) procedure is used to produce amorphous, nonconformal thin metal film coatings on a variety of substrates. The films are porous, mesh-like lattices with imperfections such as pinholes and pores, which are useful as scaffolds for cell attachment, controlled release of bioactive agents and protective coatings.Type: ApplicationFiled: August 1, 2012Publication date: February 28, 2013Applicant: METASCAPE LLCInventors: Tiffany E. Miller, Daniel M. Storey, Barbara S. Kitchell
-
Publication number: 20130013068Abstract: A method for preparing a sterilized human acellular dermal allograft where the dermal allograft is sterilized by irradiation and has a greatly reduced bio-burden and enzymatic and antigenic activity. This product line of allografts can be easily used by surgeons in soft tissue replacement or repair and has an extended shelf life, of up to at least about three years.Type: ApplicationFiled: January 4, 2010Publication date: January 10, 2013Inventors: James Forsell, Frank Fan
-
Publication number: 20130006355Abstract: The present invention relates to a method for producing artificial skin, comprising: adding a matrix metalloproteinase inhibitor and a heparanase inhibitor to an artificial skin formation culture medium comprising human epidermal keratinocytes and human dermal fibroblasts, culturing the cells in the artificial skin formation culture medium, and forming artificial skin.Type: ApplicationFiled: January 19, 2011Publication date: January 3, 2013Inventors: Shunsuke Iriyama, Kenichi Umishio, Makoto Tsunenaga, Shinji Inomata, Eijiro Adachi
-
Patent number: 8337554Abstract: A skin substitute membrane includes a surface on one side including a groove-shaped depressed portion and a planar portion, the depressed portion having a cross section having a chamfered V-letter shape, the surface having an arithmetic mean roughness Sa of more than or equal to 10 ?m to less than or equal to 50 ?m. The depressed portion has a width of more than or equal to 50 ?m to less than or equal to 500 ?m and a depth of more than or equal to 30 ?m to less than or equal to 150 ?m. A spectral transmittance for light of more than or equal to 290 nm to less than or equal to 400 nm in wavelength is more than or equal to 50% and less than or equal to 100%.Type: GrantFiled: January 10, 2012Date of Patent: December 25, 2012Assignee: Shiseido Company, Ltd.Inventors: Yoshimasa Miura, Hiroko Mizuno, Masato Hatao, Motoki Ooguri, Yusuke Hara
-
Publication number: 20120323325Abstract: A kit that may be used to process autologous skin tissue that is grafted to the patient's wound for in situ growth of new skin tissue may include: a skin collection packet, a skin processing packet, a skin tissue application packet, and a wound preparation packet.Type: ApplicationFiled: June 16, 2011Publication date: December 20, 2012Inventor: Judith A. Fulton
-
Patent number: 8292956Abstract: The present invention relates to a silicone elastomer composition for an artificial integument which satisfies the following formula: tan ??0.23?0.006X wherein tan ? represents the loss tangent of a cured product of the aforementioned composition; and X represents the Asker C hardness of a cured product of the aforementioned composition. With the composition of the present invention, an artificial integument which has not only a similar outer appearance, but also a similar flexible feeling on touch to the skin, can be obtained by a simple process.Type: GrantFiled: December 5, 2007Date of Patent: October 23, 2012Assignee: Dow Corning Toray Company, Ltd.Inventor: Wei Hong Wang
-
Patent number: 8257435Abstract: A skin integrated device for implantation with an improved device-skin interface for the ingrowths of skin cells and tissues throughout the pores, having a solid frame, which may also be permeable. The characteristics of pore size, porosity and size of the compressed and sintered particles constitute a long-term skin integrated device for transfer of vital and therapeutic substances, and necessary forces and moments from the outer delivery and prosthetics devices to the human body. The ingrowth of the skin along with the intermittent layer of fine silver provides a barrier for infection.Type: GrantFiled: September 23, 2005Date of Patent: September 4, 2012Inventors: Mark Pitkin, Grigory Raykhtsaum
-
Publication number: 20120109300Abstract: A skin substitute membrane includes a surface on one side including a groove-shaped depressed portion and a planar portion, the depressed portion having a cross section having a chamfered V-letter shape, the surface having an arithmetic mean roughness Sa of more than or equal to 10 ?m to less than or equal to 50 ?m. The depressed portion has a width of more than or equal to 50 ?m to less than or equal to 500 ?m and a depth of more than or equal to 30 ?m to less than or equal to 150 ?m. A spectral transmittance for light of more than or equal to 290 nm to less than or equal to 400 nm in wavelength is more than or equal to 50% and less than or equal to 100%.Type: ApplicationFiled: January 10, 2012Publication date: May 3, 2012Applicant: SHISEIDO COMPANY, LTD.Inventors: Yoshimasa Miura, Hiroko Mizuno, Masato Hatao, Motoki Ooguri, Yusuke Hara
-
Publication number: 20120095557Abstract: Embodiments of the present invention provide Dermal Micro-organs (DMOs), methods and apparatuses for producing the same. Some embodiments of the invention provide a DMO including a plurality of dermal components, which substantially retain the micro-architecture and three dimensional structure of the dermal tissue from which they are derived, having dimensions selected so as to allow passive diffusion of adequate nutrients and gases to cells of the DMO and diffusion of cellular waste out of the cells so as to minimize cellular toxicity and concomitant death due to insufficient nutrition and accumulation of waste in the DMO. Some embodiments of the invention provide methods and apparatuses for harvesting the DMO. An apparatus for harvesting the DMO to may include, according to some exemplary embodiments, a support configuration to support a skin-related tissue structure from which the DMO is to be harvested, and a cutting tool able to separate the DMO from the skin-related tissue structure.Type: ApplicationFiled: September 27, 2011Publication date: April 19, 2012Inventors: Stephen F. Bellomo, Itzhak Lippin, Guillermo Alberto Piva, Lior Rosenberg, Mordechay Bukhman, Baruch S. Stern, David Shalhevet, Menachem D. Shavitt, Andrew L. Pearlman, Noam Shani, Einat Almon
-
Patent number: 8105380Abstract: A cellular scaffold that is suitable for tissue regeneration, cell culture and in vitro assays. The invention relates to a layered cell scaffold that is seeded with mesenchymal and ectodermal cells. The layered cellular scaffold comprises an inoculum of mesenchymal cells and ectodermal cells positioned between two opposing scaffolds in a sandwich configuration. The layered cell scaffold provides a functional skin equivalent that is suitable for transplantation and in vitro cell-based assays.Type: GrantFiled: December 27, 2006Date of Patent: January 31, 2012Assignee: Stemedica Cell Technologies, Inc.Inventors: Alexander Kharazi, Ludmila Kharazi
-
Patent number: 8092531Abstract: The present invention relates generally to compositions for wound closure. More specifically, the present invention provides human skin equivalents engineered to express exogenous polypeptides (e.g., antimicrobial polypeptides and keratinocyte growth factor 2) and compositions and methods for making human skin equivalents engineered to express exogenous polypeptides. In addition, the present invention provides methods for treatment of wounds with human skin equivalents engineered to express exogenous polypeptides.Type: GrantFiled: January 20, 2010Date of Patent: January 10, 2012Assignee: Stratatech CorporationInventors: John M. Centanni, B. Lynn Allen-Hoffmann
-
Publication number: 20110274756Abstract: Tissue regeneration or grafting is promoted utilizing a structure including a multi-layer sheet of collagen membrane material which includes a purified collagen barrier sheet material derived from natural collagen-containing tissue, the barrier sheet material including a barrier layer with an outer smooth barrier face and a fibrous face opposite the smooth barrier face. The structure further includes a matrix layer of collagen sponge material adjacent to the fibrous face. The matrix layer of collagen sponge material is resorbed by a body of a subject at a substantially faster rate than the barrier sheet material.Type: ApplicationFiled: January 18, 2010Publication date: November 10, 2011Applicant: GEISTLICH PHARMA AGInventors: Peter Geistlich, Lothar Schloesser
-
Publication number: 20110270394Abstract: Skin regeneration or grafting is promoted utilizing a structure including a multi-layer sheet of collagen membrane material which includes a purified collagen barrier sheet material derived from natural collagen-containing tissue, the barrier sheet material including a barrier layer with an outer smooth barrier face and a fibrous face opposite the smooth barrier face. The structure further includes a matrix layer of collagen sponge material adjacent to the fibrous face. The matrix layer of collagen sponge material is resorbed by a body of a subject at a substantially faster rate than the barrier sheet material.Type: ApplicationFiled: January 18, 2010Publication date: November 3, 2011Applicant: GEISTLICH PHARMA AGInventors: Alan S. Herford, Lothar Schloesser, Peter Geistlich
-
Patent number: 8049059Abstract: A tissue graft product includes at least one collagen layer comprised of submucosa or renal capsule tissue having slits therein to provide a mesh pattern which in turn establishes a graft structure that is highly deformable. The slits and mesh pattern provide for improved characteristics when utilized as a tissue graft and in particular an external wound care. Preferred devices have multiple submucosa, renal capsule or other collagenous extracellular matrix layers, providing a substantial and lasting scaffold for tissue ingrowth during wound treatment.Type: GrantFiled: October 25, 2002Date of Patent: November 1, 2011Assignee: Cook Biotech IncorporatedInventors: Mark W. Bleyer, Umesh H. Patel
-
Patent number: 7955790Abstract: The present invention relates to in vitro cultured skin substitutes, and in particular to in vitro cultured skin substitutes that have improved barrier function. In some embodiments, improved barrier function is a result of improved culture conditions, while in other embodiments, improved barrier function results from genetic modification of keratinocytes. Improved culture conditions to improve barrier function include organotypic culture in the presence of linoleic acid and/or linoleic acid at about 75% humidity. Suitable genetic modifications for improving barrier function includes transfection with a DNA construct capable of expressing GKLF.Type: GrantFiled: July 16, 2008Date of Patent: June 7, 2011Assignee: Stratatech CorporationInventors: Allen Comer, Lynn Allen-Hoffmann, Michael Hoffmann